Building a connected clinical trials platform for Australian research

Clinical trials increasingly depend on collaboration between hospitals, universities, research institutes, sponsors, patients and community organisations. When these groups use separate databases, spreadsheets and email chains, essential information can become difficult to locate. Recruitment slows, reporting is duplicated and investigators may struggle to see where a study stands across multiple sites.

Developing a digital platform for coordinating clinical trials across research institutes can create a shared operational layer for this complex environment. In Brisbane and across Queensland, such a system could connect health services, academic partners and research teams while supporting the governance, privacy and practical requirements of Australian clinical research.

Define the problems the platform must solve

A useful platform should begin with the daily needs of trial coordinators, principal investigators, research offices and participants. Core functions may include study registration, site activation, feasibility assessments, participant recruitment, consent tracking, data quality checks, monitoring visits and milestone reporting. A single source of truth can reduce repeated data entry and make responsibilities visible.

The platform should also support different study designs, from investigator-led trials to commercially sponsored projects and embedded health service research. Configurable workflows are important because a cancer trial, a mental health intervention and a maternal health study may require different eligibility, consent and follow-up processes.

Stakeholder mapping should include Aboriginal and Torres Strait Islander health organisations, rural services, consumers and carers. Their needs may differ from those of large metropolitan hospitals. Early co-design can prevent a platform from becoming an administrative tool that serves institutions while creating additional work for communities and frontline staff.

Create an architecture that supports collaboration

Interoperability should be a central design principle. A trial management system may need to exchange information with electronic medical records, pathology systems, pharmacy platforms, secure survey tools and institutional identity services. Standards-based application programming interfaces can help avoid isolated software and support future integration as systems change.

Access should be based on clearly defined roles. A site coordinator may need participant and visit information, while a sponsor could require aggregate progress reports and a research office may need governance documentation. Strong authentication, audit trails, encryption and automated access reviews are essential for protecting sensitive health information.

The platform should be designed for Australian infrastructure and policy settings. It must align with the Privacy Act, relevant state and territory requirements, the National Statement on Ethical Conduct in Human Research and expectations from the Therapeutic Goods Administration. Where clinical information connects with broader care records, teams should also consider how the system relates to Australian digital health services such as My Health Record without creating inappropriate data flows.

Build governance into every workflow

Governance cannot be treated as a document uploaded at the beginning of a project. A digital system should track ethics submissions, site-specific authorisations, contracts, safety reporting, protocol amendments, delegation logs and training records. Automated reminders can identify approaching deadlines before they affect recruitment or data integrity.

A shared framework is particularly valuable when a study spans Queensland Health facilities, universities and independent research organisations. The Brisbane Diamantina network demonstrates the value of connecting research capability with health services and communities, providing a relevant environment for collaborative translation and clinical innovation.

Clear accountability should be visible in the platform. Every approval, change and decision needs a time-stamped record, with document versions and responsible officers easy to identify. Teams planning a multi-site programme can also use this multi-site governance guide to consider how responsibilities, reporting lines and oversight arrangements should be represented digitally.

Design for recruitment, participation and retention

Recruitment tools should help researchers understand where eligible participants may be found without exposing unnecessary personal information. Dashboards can show recruitment progress by site, referral source, age group or other approved categories. This supports timely action when a study is failing to reach rural communities, younger people or culturally diverse populations.

Participant-facing features may include plain-language study information, electronic consent, appointment reminders, symptom diaries and secure messaging. Digital consent should complement conversations with clinicians and interpreters, rather than replacing informed discussion. Accessibility is especially important for people with disability, limited digital confidence, low health literacy or inconsistent internet access.

Queensland’s geography makes flexible participation essential. A trial coordinated from Brisbane may include sites in Cairns, Townsville, the Gold Coast or regional areas where travel to a tertiary hospital is expensive and time-consuming. Telehealth visits, local pathology collection and mobile-friendly follow-up can reduce this burden, while paper or telephone alternatives ensure that digital participation is not compulsory.

Measure performance and improve the system

A platform should provide meaningful operational intelligence rather than produce dashboards for their own sake. Useful measures include time from expression of interest to activation, ethics review duration, recruitment and retention rates, protocol deviations, data query turnaround and the proportion of participants completing follow-up. Measures should be interpreted with context, particularly when comparing metropolitan and regional sites.

Data quality rules can identify missing dates, inconsistent eligibility fields and overdue assessments early. Role-specific dashboards allow a coordinator to focus on immediate tasks while an executive views programme-level performance. De-identified reporting can support funders, governance committees and health service leaders without widening access to identifiable participant information.

Implementation should follow a staged path. A pilot involving a small number of research institutes and health services can test workflows before broader deployment. Training, local champions, responsive technical support and clear escalation channels will influence adoption as much as the software itself. The platform should also be reviewed regularly against changes in regulation, cybersecurity threats, research practice and participant expectations.

Clinical trial coordination is a long-term capability, so procurement should examine the Australian vendor market, hosting arrangements, integration costs and the availability of support staff. A low-cost product that cannot scale across Queensland or meet governance obligations may become more expensive than a carefully planned system with durable foundations.

Research leaders can begin by mapping current trial processes, identifying duplicated work and agreeing on shared data definitions. Bringing together consumers, clinicians, coordinators, governance officers, information technology teams and community partners will create a platform shaped by real practice. With strong governance and a focus on equitable participation, digital coordination can help Australian research move more efficiently from discovery to better care.